PIMA544759

TPMT Recombinant Rabbit Monoclonal Antibody (JE64-09), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA544759-Each-of-1 In Stock ₹ 42,720.00

PIMA544759 - Each of 1

₹ 42,720.00

In Stock

Quantity

1

Base Price: ₹ 42,720.00

GST (18%): ₹ 7,689.60

Total Price: ₹ 50,409.60

Antigen

TPMT

Classification

Recombinant Monoclonal

Concentration

1 mg/mL

Formulation

TBS with 0.05% BSA, 40% glycerol and 0.05% sodium azide; pH 7.4

Gene Accession No.

O55060, P51580, Q9Z0T0

Gene Symbols

TPMT

Immunogen

Synthetic peptide within human TPMT aa 101-150/245.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Form

Liquid

Applications

Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot

Clone

JE64-09

Conjugate

Unconjugated

Gene

TPMT

Gene Alias

AW106912; HGNC:12014; S-adenosyl-L-methionine:thiopurine S-methyltransferase; thiopurine methyltransferase; Thiopurine S-methyltransferase; TPMT; TPMTD; truncated thiopurine methyltransferase

Host Species

Rabbit

Purification Method

Protein A

Regulatory Status

RUO

Gene ID (Entrez)

22017, 690050, 7172

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Isotype

IgG

Related Products

Img

Thermo Scientific

PIMA544725

--

Img

Novus Biologicals

NP197939A70

--

Img

Thermo Scientific

PIMA544624

--

Img

Thermo Scientific

PIMA536190

--

Img

Thermo Scientific

PIPA553724

--

Img

Thermo Scientific

PI720311

--

Img

Thermo Scientific

PIPA5143912

--

Img

Thermo Scientific

PIMA547439

--

Description

  • Catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine
  • Defects in TPMT are the cause of thiopurine S-methyltransferase deficiency (TPMT deficiency)
  • TPMT is an enzyme involved in the normal metabolic inactivation of thiopurine drugs
  • These drugs are generally used as immunosupressants or cytotoxic drugs and are prescribed for a variety of clinical conditions including leukemia, autoimmune disease and organ transplantation
  • Patients with intermediate or no TPMT activity are at risk of toxicity after receiving standard doses of thiopurine drugs and it is shown that inter-individual differences in response to these drugs are largely determined by genetic variation at the TPMT locus.